| 臺大學術典藏 |
2020-08-13T06:33:54Z |
Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers
|
Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:54Z |
Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas
|
Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C.; Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:52Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Lee Y.-C.; Tsai M.-F.; Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Yu C.-J.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:51Z |
EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy
|
Chang Y.-L.;Wu C.-T.;Jin-Yuan Shih;Lee Y.-C.; Chang Y.-L.; Wu C.-T.; JIN-YUAN SHIH; Lee Y.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:50Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
JIN-YUAN SHIH; Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:48Z |
The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction
|
Lee Y.-C.; Wu C.-T.; JIN-YUAN SHIH; Lin M.-W.; Chang Y.-L.;Lin M.-W.;Jin-Yuan Shih;Wu C.-T.;Lee Y.-C.; Chang Y.-L. |
| 臺大學術典藏 |
2020-08-13T06:33:45Z |
Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ?2 cm in maximal dimension
|
Lin M.-W.; Wu C.-T.; JIN-YUAN SHIH; Chang Y.-L.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Tsai T.-H.; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.;Shang-Gin Wu;Chang Y.-L.;Wu C.-T.;Tsai M.-F.;Wei P.-F.;Yang C.-H.;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Shang-Gin Wu ;Chang Y.-L. ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; SHANG-GIN WU; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:35:35Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:15Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T02:50:36Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y. |
| 臺大學術典藏 |
2020-08-12T02:50:35Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:19Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Yang P.-C.; Shih J.-Y.; Yu C.-J.; Yang C.-H.; TZU-HSIU TSAI; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F. |
| 臺大學術典藏 |
2020-07-21T06:09:18Z |
The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms
|
Chang Y.-L.;Lee Y.-C.;Wei-Yu Liao;Wu C.-T.; Chang Y.-L.; Lee Y.-C.; WEI-YU LIAO; Wu C.-T. |
| 臺大學術典藏 |
2020-07-21T06:09:03Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C. |
| 臺大學術典藏 |
2020-07-21T05:40:34Z |
Programmed cell death-ligand 1 expression in surgically resected stage i pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes
|
Yang P.-C.; Wu C.-T.; Chang Y.-L.; Lin M.-W.; CHING-YAO YANG; Ching-Yao Yang;Lin M.-W.;Chang Y.-L.;Wu C.-T.;Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T05:40:32Z |
High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma
|
Yang P.-C.; Wu C.-T.; Lin M.-W.; CHING-YAO YANG; Chang Y.-L. |
| 臺大學術典藏 |
2020-07-21T05:40:31Z |
The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas
|
CHING-YAO YANG; Kuo S.-W.; Wu C.-T.; Chang Y.-L.; Yang P.-C.; Lin M.-W. |
| 臺大學術典藏 |
2020-07-21T05:40:30Z |
Globo H expression is associated with driver mutations and PD-L1 expressions in stage i non-small cell lung cancer
|
Lin M.-W.; Chang Y.-L.; Wu C.-T.; CHING-YAO YANG; Ching-Yao Yang;Lin M.-W.;Chang Y.-L.;Wu C.-T. |
| 臺大學術典藏 |
2020-07-21T05:40:29Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Lee J.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Ching-Yao Yang;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; CHING-YAO YANG; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-07-05T01:54:04Z |
The role of endoplasmic reticulum stress-related unfolded protein response in the radiocontrast medium-induced renal tubular cell injury
|
Chiang C.K.; Liu S.H.; TE-I WENG; Tsai K.S.; Sheu M.L.; Wu C.T.; Wu C.T.;Sheu M.L.;Tsai K.S.;Te-I Weng;Chiang C.K.;Liu S.H. |
| 臺大學術典藏 |
2020-07-03T04:00:32Z |
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
|
Wu M.-F.; Wu C.-T.; HSIN-CHIH LAI; Lee L.-N.; Chiang B.-L.; Yu C.-J.; Wang J.-Y.; Shu C.-C.; Shu C.-C.;Wang J.-Y.;Wu M.-F.;Wu C.-T.;Hsin-Chih Lai;Lee L.-N.;Chiang B.-L.;Yu C.-J. |
| 臺大學術典藏 |
2020-07-01T08:12:26Z |
Comparisons and performance evaluations of RNA-seq alignment tools
|
Wang W.-A.;Wu C.-T.;Lu T.-P.;Tsai M.-H.;Liang-Chuan Lai;Chuang E.Y.; Wang W.-A.; Wu C.-T.; Lu T.-P.; Tsai M.-H.; LIANG-CHUAN LAI; Chuang E.Y. |
| 臺大學術典藏 |
2020-07-01T06:20:03Z |
Intracortical osteosarcoma: Report of a case
|
Shu-Hua Yang;Wu C.-T.;Wang C.-J.;Kuo M.-S.;Yang R.-S.; SHU-HUA YANG; Wu C.-T.; Wang C.-J.; Kuo M.-S.; Yang R.-S. |
| 臺大學術典藏 |
2020-06-30T08:09:52Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:51Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T06:13:45Z |
Mycotic Aneurysm Caused by Streptococcus constellatus subsp. constellatus
|
Chiang W.-C.;Tsai J.-C.;Chen S.-Y.;Hsu C.-Y.;Wu C.-T.;Lee-Jene Teng;Hsueh P.-R.; Chiang W.-C.; Tsai J.-C.; Chen S.-Y.; Hsu C.-Y.; Wu C.-T.; LEE-JENE TENG; Hsueh P.-R. |
| 臺大學術典藏 |
2020-06-24T08:45:29Z |
Spatial Attention Disregard in Children With Hemiplegic Cerebral Palsy
|
Tien-Ni Wang;Liang K.-J.;Howe T.-H.;Chen H.-L.;Huang C.-W.;Wu C.-T.; TIEN-NI WANG; Liang K.-J.; Howe T.-H.; Chen H.-L.; Huang C.-W.; Wu C.-T. |
| 臺大學術典藏 |
2020-06-24T08:04:38Z |
Responsiveness and predictive validity of the computerized digit vigilance test in patients with stroke
|
Sheau-Ling Huang;Chen T.-T.;Lin G.-H.;Wu C.-T.;Hsueh I.-P.;Hsieh C.-L.; SHEAU-LING HUANG; Chen T.-T.; Lin G.-H.; Wu C.-T.; Hsueh I.-P.; Hsieh C.-L. |
| 臺大學術典藏 |
2020-06-24T05:52:14Z |
Psychometric properties of the Five-Digit Test in patients with stroke
|
Lin G.-H.; Lu Y.; Wu C.-T.; Chiu E.-C.; Huang S.-L.; I-PING HSUEH; Hsieh C.-L.; Lin G.-H.;Lu Y.;Wu C.-T.;Chiu E.-C.;Huang S.-L.;I-Ping Hsueh;Hsieh C.-L. |
| 臺大學術典藏 |
2020-06-24T05:52:13Z |
A comparison between the original and Tablet-based Symbol Digit Modalities Test in patients with schizophrenia: Test-retest agreement, random measurement error, practice effect, and ecological validity
|
Tang S.-F.;Chen I.-H.;Chiang H.-Y.;Wu C.-T.;I-Ping Hsueh;Yu W.-H.;Hsieh C.-L.; Tang S.-F.; Chen I.-H.; Chiang H.-Y.; Wu C.-T.; I-PING HSUEH; Yu W.-H.; Hsieh C.-L. |
| 臺大學術典藏 |
2020-06-24T05:52:12Z |
Responsiveness and predictive validity of the computerized digit vigilance test in patients with stroke
|
Chen T.-T.; Lin G.-H.; Wu C.-T.; I-PING HSUEH; Hsieh C.-L.; Huang S.-L.; Huang S.-L.;Chen T.-T.;Lin G.-H.;Wu C.-T.;I-Ping Hsueh;Hsieh C.-L. |
| 臺大學術典藏 |
2020-06-18T06:10:39Z |
Synergistic optimization of thermoelectric performance of Sb doped GeTe with a strained domain and domain boundaries
|
Chen, L.-C.;Sankar, R.;Chou, F.-C.;Chen, K.-H.;Wu, C.T.;Bayikadi, K.S.; Bayikadi, K.S.; Wu, C.T.; Chen, L.-C.; Chen, K.-H.; Chou, F.-C.; Sankar, R. |
| 臺大學術典藏 |
2020-06-17T03:01:42Z |
Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type i interferon
|
Ho B.-C.;Yu I.-S.;Lu L.-F.;Rudensky A.;Chen H.-Y.;Tsai C.-W.;Chang Y.-L.;Wu C.-T.;Chang L.-Y.;Shih S.-R.;Lin S.-W.;Lee C.-N.;Yang P.-C.;Sung-Liang Yu; Ho B.-C.; Yu I.-S.; Lu L.-F.; Rudensky A.; Chen H.-Y.; Tsai C.-W.; Chang Y.-L.; Wu C.-T.; Chang L.-Y.; Shih S.-R.; Lin S.-W.; Lee C.-N.; Yang P.-C.; SUNG-LIANG YU |
| 臺大學術典藏 |
2020-06-17T03:01:28Z |
Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 06 Biological Sciences 0601 Biochemistry and Cell Biology
|
Hung P.-F.;Hong T.-M.;Chang C.-C.;Hung C.-L.;Hsu Y.-L.;Chang Y.-L.;Wu C.-T.;Chang G.-C.;Chan N.-L.;Sung-Liang Yu;Yang P.-C.;Pan S.-H.; Hung P.-F.; Hong T.-M.; Chang C.-C.; Hung C.-L.; Hsu Y.-L.; Chang Y.-L.; Wu C.-T.; Chang G.-C.; Chan N.-L.; SUNG-LIANG YU; Yang P.-C.; Pan S.-H. |
| 臺大學術典藏 |
2020-06-11T06:44:59Z |
Visibility enhancement of single hazy images using hybrid dark channel prior
|
Cheng, Y.-J.;Chen, B.-H.;Huang, S.-C.;Kuo, S.-Y.;Kopylov, A.;Seredin, O.;Mestetskiy, L.;Vishnyakov, B.;Vizilter, Y.;Vygolov, O.;Lian, C.-R.;Wu, C.-T.; Cheng, Y.-J.; Chen, B.-H.; Huang, S.-C.; Kuo, S.-Y.; Kopylov, A.; Seredin, O.; Mestetskiy, L.; Vishnyakov, B.; Vizilter, Y.; Vygolov, O.; Lian, C.-R.; Wu, C.-T.; SY-YEN KUO |
| 臺大學術典藏 |
2020-06-11T06:20:29Z |
Voltage Transfer Characteristic Matching by Different Nanosheet Layer Numbers of Vertically Stacked Junctionless CMOS Inverter for SoP/3D-ICs applications
|
Wu, C.-T.; Huang, Y.-M.; Hou, F.-J.; Luo, G.-L.; Huang, Y.-C.; Shen, Y.-L.; Ma, W.C.-Y.; Huang, K.-P.; Lin, K.-L.; Samukawa, S.; Li, Y.; Huang, G.-W.; Lee, Y.-J.; Li, J.-Y.; Wu, W.-F.; Shieh, J.-M.; Chao, T.-S.; Yeh, W.-K.; Wang, Y.-H.; JIUN-YUN LI; Sung, P.-J.;Chang, C.-Y.;Chen, L.-Y.;Kao, K.-H.;Su, C.-J.;Liao, T.-H.;Fang, C.-C.;Wang, C.-J.;Hong, T.-C.;Jao, C.-Y.;Hsu, H.-S.;Luo, S.-X.;Wang, Y.-S.;Huang, H.-F.;Li, J.-H.;Huang, Y.-C.;Hsueh, F.-K.;Wu, C.-T.;Huang, Y.-M.;Hou, F.-J.;Luo, G.-L.;Huang, Y.-C.;Shen, Y.-L.;Ma, W.C.-Y.;Huang, K.-P.;Lin, K.-L.;Samukawa, S.;Li, Y.;Huang, G.-W.;Lee, Y.-J.;Li, J.-Y.;Wu, W.-F.;Shieh, J.-M.;Chao, T.-S.;Yeh, W.-K.;Wang, Y.-H.; Sung, P.-J.; Hsueh, F.-K.; Huang, Y.-C.; Li, J.-H.; Huang, H.-F.; Chang, C.-Y.; Chen, L.-Y.; Kao, K.-H.; Su, C.-J.; Liao, T.-H.; Fang, C.-C.; Wang, C.-J.; Hong, T.-C.; Jao, C.-Y.; Hsu, H.-S.; Luo, S.-X.; Wang, Y.-S. |
| 臺大學術典藏 |
2020-06-11T06:12:10Z |
Method for suppressing the mirror image in Fourierdomain optical coherence tomography
|
Wu, C.-T.;Chi, T.-T.;Lee, C.-K.;Kiang, Y.-W.;Yang, C.-C.;Chiang, C.-P.; Wu, C.-T.; Chi, T.-T.; Lee, C.-K.; Kiang, Y.-W.; Yang, C.-C.; Chiang, C.-P.; YEAN-WOEI KIANG |
| 臺大學術典藏 |
2020-06-01T06:57:20Z |
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour
|
Lee J.-C.;Jeng Y.-M.;Su S.-Y.;Wu C.-T.;Tsai K.-S.;Lee C.-H.;Lin C.-Y.;Carter J.M.;Huang J.-W.;Chen S.-H.;Shyang-Rong Shih;Mari?O-Enr?Quez A.;Chen C.-C.;Folpe A.L.;Chang Y.-L.;Liang C.-W.; Lee J.-C.; Jeng Y.-M.; Su S.-Y.; Wu C.-T.; Tsai K.-S.; Lee C.-H.; Lin C.-Y.; Carter J.M.; Huang J.-W.; Chen S.-H.; SHYANG-RONG SHIH; Mari?o-Enr?quez A.; Chen C.-C.; Folpe A.L.; Chang Y.-L.; Liang C.-W. |
| 臺大學術典藏 |
2020-05-26T09:27:19Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H; Chang Y.-L; Hsu Y.-C; Tsai M.-F; Wu C.-T; Yu C.-J; CHIH-HSIN YANG; Lee Y.-C; Yang P.-C; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-26T09:26:17Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y;Liao W.-Y;Ho C.-C;Chen K.-Y;Tsai T.-H;Hsu C.-L;Su K.-Y;Chang Y.-L;Wu C.-T;Hsu C.-C;Liao B.-C;Hsu W.-H;Lee J.-H;Lin C.-C;Shih J.-Y;Chih-Hsin Yang;Yu C.-J.; Yang C.-Y; Liao W.-Y; Ho C.-C; Chen K.-Y; Tsai T.-H; Hsu C.-L; Su K.-Y; Chang Y.-L; Wu C.-T; Hsu C.-C; Liao B.-C; Hsu W.-H; Lee J.-H; Lin C.-C; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J. |
| 臺大學術典藏 |
2020-05-25T07:45:55Z |
A precious experience of lobar transplantation in a teenager with end-stage chronic hypersensitivity pneumonia: Case report
|
Chang Y.-L.;Wu C.-T.;Pei-Ming Huang;Shu H.-S.;Lee Y.-C.; Chang Y.-L.; Wu C.-T.; PEI-MING HUANG; Shu H.-S.; Lee Y.-C. |
| 臺大學術典藏 |
2020-05-25T07:35:03Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H; Shih J.-Y; Yang C.-Y; Liao W.-Y; Ho C.-C; Chen K.-Y; Tsai T.-H; Hsu C.-L; Liu Y.-N; Su K.-Y; Chang Y.-L; Wu C.-T; Liao B.-C; Hsu C.-C; Hsu W.-H; Lee J.-H; Chia-Chi Lin |
| 臺大學術典藏 |
2020-05-25T07:35:02Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y; Liao W.-Y; Ho C.-C; Chen K.-Y; Tsai T.-H; Hsu C.-L; Su K.-Y; Chang Y.-L; Wu C.-T; Hsu C.-C; Liao B.-C; Hsu W.-H; Lee J.-H; Chia-Chi Lin; Shih J.-Y; Yang J.C.-H; Yu C.-J. |
| 臺大學術典藏 |
2020-05-25T07:32:50Z |
A precious experience of lobar transplantation in a teenager with end-stage chronic hypersensitivity pneumonia: Case report
|
PEI-MING HUANG;Lee Y.-C.;Shu H.-S.;Wu C.-T.;Chang Y.-L.; Chang Y.-L.; Wu C.-T.; PEI-MING HUANG; Shu H.-S.; Lee Y.-C. |
| 臺大學術典藏 |
2020-05-19T01:53:11Z |
Surgical lung biopsy for diffuse pulmonary disease: Experience of 196 patients
|
Lee Y.-C.;Wu C.-T.;Hsu H.-H.;Pei-Ming Huang;Chang Y.-L.; Lee Y.-C.; Wu C.-T.; Hsu H.-H.; PEI-MING HUANG; Chang Y.-L. |
